ClinVar Miner

Submissions for variant NM_001079668.3(NKX2-1):c.935dup (p.Gln313fs)

dbSNP: rs1594403511
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 1
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Johns Hopkins Genomics, Johns Hopkins University RCV000787039 SCV000925954 likely pathogenic Brain-lung-thyroid syndrome 2019-03-25 criteria provided, single submitter clinical testing This frameshift variant is predicted to lead to a new stop codon that is downstream of the native stop codon. The resulting transcript is not expected to undergo nonsense-mediated decay and likely results in an extended protein product (125 novel C-terminal amino acids replacing the last 89 amino acids of NKX2-1). The glutamine rich region, predicted to be missing from the resulting protein, has an important role in NKX2-1 transactivation. This NKX2-1 variant is absent* from large population datasets and has not been reported in ClinVar nor the literature, to our knowledge. This variant is considered likely pathogenic.

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.